Yttrium-90 Radioembolization for Hepatocellular Carcinoma

http://www.sciencedirect.com/science/article/pii/S0001299815001348

Seminars in Nuclear Medicine
Volume 46, Issue 2, March 2016, Pages 105–108
Radiolabeled Agents in Cancer Therapy (Part I)

Conclusion

Radioembolization is a locoregional therapy for HCC that relies on precise, intra-arterial administration of microspheres labeled with the radionuclide ⁹⁰Y to tumor-bearing hepatic tissue. Radioembolization offers significant survival benefits to patients with intermediate- and advanced-stage HCC, whereas advanced dosimetry and administration techniques are expanding the potential for curative therapies.
--------------------

I do like 'Radioembolization offers significant survival benefits to patients with intermediate- and advanced-stage HCC, whereas advanced dosimetry and administration techniques are expanding the potential for curative therapies.'